“Goldman Sachs Sees These 2 Stocks Surging Over 70%”
September 16, 2021
“Dole Plc (DOLE)…
Overall, the recent analyst reviews on DOLE, breaking down to 3 Buys, 1 Hold, and 1 Sell, give the stock a Moderate Buy consensus rating. Shares are priced at $14.87 and the average price target of $19.60 implies a one-year upside of 32%…
Terns Pharmaceuticals (TERN)…
Small-cap biopharmas don’t always get a lot of analyst attention – they tend to fly under the radar. However, there are two reviews on file here and both are to Buy, making the consensus rating a Moderate Buy. TERN shares are priced at $10.71, with an average price target of $20, indicating a runway toward ~87% upside for 2021…”
https://finance.yahoo.com/news/goldman-sachs-sees-2-stocks-220742710.html